Literature DB >> 23763999

NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression.

Tomoya Yamaguchi1, Yasuyuki Hosono, Kiyoshi Yanagisawa, Takashi Takahashi.   

Abstract

Emerging evidence indicates that NKX2-1, a homeobox-containing transcription factor also known as TTF-1, plays a role as a "lineage-survival" oncogene in lung adenocarcinomas. In T cell acute lymphoblastic leukemia, gene rearrangements lead to aberrant expression of NKX2-1/TTF-1. Despite accumulating evidence supporting its oncogenic role, it has become apparent that NKX2-1/TTF-1 expression also has biological and clinical functions in the opposite direction that act against tumor progression. Herein, we review recent findings showing these enigmatic double-edged characteristics, with special attention given to the roles of NKX2-1/TTF-1 in lung development and carcinogenesis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23763999     DOI: 10.1016/j.ccr.2013.04.002

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  61 in total

1.  Adipogenic Differentiation of Thyroid Cancer Cells Through the Pax8-PPARγ Fusion Protein Is Regulated by Thyroid Transcription Factor 1 (TTF-1).

Authors:  Bin Xu; Michael O'Donnell; Jeffrey O'Donnell; Jingcheng Yu; Yanxiao Zhang; Maureen A Sartor; Ronald J Koenig
Journal:  J Biol Chem       Date:  2016-07-19       Impact factor: 5.157

2.  An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.

Authors:  Robert J G Cardnell; Carmen Behrens; Lixia Diao; YouHong Fan; Ximing Tang; Pan Tong; John D Minna; Gordon B Mills; John V Heymach; Ignacio I Wistuba; Jing Wang; Lauren A Byers
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

3.  Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively.

Authors:  Jia Liu; Su Dong; Heather Wang; Lian Li; Qinmao Ye; Yanhui Li; Jiaxing Miao; Sissy Jhiang; Jing Zhao; Yutong Zhao
Journal:  FASEB J       Date:  2019-06-25       Impact factor: 5.191

4.  TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas.

Authors:  Z Liu; K Yanagisawa; S Griesing; M Iwai; K Kano; N Hotta; T Kajino; M Suzuki; T Takahashi
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

5.  Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.

Authors:  Ruifang Sun; Zhigang Liu; Gang Ma; Weidong Lv; Xinliang Zhao; Guangyan Lei; Changfu Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

6.  Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expression.

Authors:  Ming-Jenn Chen; Po-Ming Chen; Lee Wang; Ching-Ju Shen; Chi-Yi Chen; Huei Lee
Journal:  Am J Cancer Res       Date:  2020-04-01       Impact factor: 6.166

7.  Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial-mesenchymal transition phenotype.

Authors:  Yuji Sakuma; Hirotaka Nishikiori; Sachie Hirai; Miki Yamaguchi; Gen Yamada; Atsushi Watanabe; Tadashi Hasegawa; Takashi Kojima; Toshiro Niki; Hiroki Takahashi
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

8.  ROR1-CAVIN3 interaction required for caveolae-dependent endocytosis and pro-survival signaling in lung adenocarcinoma.

Authors:  Tomoya Yamaguchi; Miyu Hayashi; Lisa Ida; Masatoshi Yamamoto; Can Lu; Taisuke Kajino; Jinglei Cheng; Masahiro Nakatochi; Hisanori Isomura; Masaya Yamazaki; Motoshi Suzuki; Toyoshi Fujimoto; Takashi Takahashi
Journal:  Oncogene       Date:  2019-03-20       Impact factor: 9.867

Review 9.  Lineage factors and differentiation states in lung cancer progression.

Authors:  W K C Cheung; D X Nguyen
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

Review 10.  [Molecular pathology of lung cancer. State of the art 2014].

Authors:  A Warth; V Endris; R Penzel; W Weichert
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.